Osteoarticular Infections in Infants Under 3 Months of Age
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.17/4508 |
Resumo: | Background: Acute osteoarticular infections (OAI) in infants under 3 months of age (≤3M) are rare and remain a diagnostic challenge. Orthopedic complications and functional sequelae have been less well described in this age group. Our aims were to evaluate trends in aetiology, management, and outcomes of OAI ≤ 3M, and to compare these younger children who have OAI with older children. Methods: A longitudinal observational study was conducted of OAI cases admitted to tertiary care pediatric hospital from 2008 to 2018. OAI ≤ 3M was compared with children above 3 months. Clinical, microbiological, imaging, and outcome data were analyzed. Results: We identified 24 (9.1%) of the 263 OAI in children under 3 months. Analyzing OAI ≤ 3M there was a twofold increase since 2014; 54% were males with a median age of 28 days (IQR: 13.5-60.0), 10 (41.7%) were premature and nine (37.5%) had healthcare-associated infections. Microbiological causes were identified in 87.5%, mostly Staphylococcus aureus (57.1%) and Group B Streptococcus (23.8%), and 25% were multidrug-resistant (5 methicillin-resistant S. aureus and 1 Enterobacter cloacae). Bacteremia (100% vs 36.8%, P = 0.037), multidrug resistant bacteria (75% vs 16, P = 0.04), and healthcare-associated infections (100% vs 26.3%, P = 0.014) were associated with sequelae. Comparing OAI ≤ 3M with older children, OAI ≤ 3M were treated with longer antibiotic courses, had more complications and sequelae (17.4% vs 3.2%, P = 0.002). Conclusions: S. aureus is still the most common cause of OAI ≤ 3M, and 25% of causative bacteria were multidrug-resistant bacteria. Complications and sequelae were more frequent in OAI ≤ 3M when compared with older children. |
id |
RCAP_90fa3787f9c0ba7655c387c6c92f251a |
---|---|
oai_identifier_str |
oai:repositorio.chlc.min-saude.pt:10400.17/4508 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Osteoarticular Infections in Infants Under 3 Months of AgeAdolescentAnti-Bacterial Agents / therapeutic useBacteremia* / microbiologyChildCross Infection* / drug therapyInfantFemaleMaleMethicillin-Resistant Staphylococcus aureus*Osteomyelitis* / diagnosisOsteomyelitis* / epidemiologyOsteomyelitis* / therapyRetrospective StudiesStaphylococcal Infections* / diagnosisStaphylococcal Infections* / drug therapyStaphylococcal Infections* / epidemiologyStaphylococcus aureusHDE INF PEDHDE ORT PEDHDE IMABackground: Acute osteoarticular infections (OAI) in infants under 3 months of age (≤3M) are rare and remain a diagnostic challenge. Orthopedic complications and functional sequelae have been less well described in this age group. Our aims were to evaluate trends in aetiology, management, and outcomes of OAI ≤ 3M, and to compare these younger children who have OAI with older children. Methods: A longitudinal observational study was conducted of OAI cases admitted to tertiary care pediatric hospital from 2008 to 2018. OAI ≤ 3M was compared with children above 3 months. Clinical, microbiological, imaging, and outcome data were analyzed. Results: We identified 24 (9.1%) of the 263 OAI in children under 3 months. Analyzing OAI ≤ 3M there was a twofold increase since 2014; 54% were males with a median age of 28 days (IQR: 13.5-60.0), 10 (41.7%) were premature and nine (37.5%) had healthcare-associated infections. Microbiological causes were identified in 87.5%, mostly Staphylococcus aureus (57.1%) and Group B Streptococcus (23.8%), and 25% were multidrug-resistant (5 methicillin-resistant S. aureus and 1 Enterobacter cloacae). Bacteremia (100% vs 36.8%, P = 0.037), multidrug resistant bacteria (75% vs 16, P = 0.04), and healthcare-associated infections (100% vs 26.3%, P = 0.014) were associated with sequelae. Comparing OAI ≤ 3M with older children, OAI ≤ 3M were treated with longer antibiotic courses, had more complications and sequelae (17.4% vs 3.2%, P = 0.002). Conclusions: S. aureus is still the most common cause of OAI ≤ 3M, and 25% of causative bacteria were multidrug-resistant bacteria. Complications and sequelae were more frequent in OAI ≤ 3M when compared with older children.WileyRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEBranco, JDuarte, MNorte, SArcangelo, JAlves, PBrito, MTavares, DGouveia, C2023-05-04T11:56:49Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4508engPediatr Int . 2022 Jan;64(1):e1521210.1111/ped.15212info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-05-07T05:44:25Zoai:repositorio.chlc.min-saude.pt:10400.17/4508Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:51:00.230386Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Osteoarticular Infections in Infants Under 3 Months of Age |
title |
Osteoarticular Infections in Infants Under 3 Months of Age |
spellingShingle |
Osteoarticular Infections in Infants Under 3 Months of Age Branco, J Adolescent Anti-Bacterial Agents / therapeutic use Bacteremia* / microbiology Child Cross Infection* / drug therapy Infant Female Male Methicillin-Resistant Staphylococcus aureus* Osteomyelitis* / diagnosis Osteomyelitis* / epidemiology Osteomyelitis* / therapy Retrospective Studies Staphylococcal Infections* / diagnosis Staphylococcal Infections* / drug therapy Staphylococcal Infections* / epidemiology Staphylococcus aureus HDE INF PED HDE ORT PED HDE IMA |
title_short |
Osteoarticular Infections in Infants Under 3 Months of Age |
title_full |
Osteoarticular Infections in Infants Under 3 Months of Age |
title_fullStr |
Osteoarticular Infections in Infants Under 3 Months of Age |
title_full_unstemmed |
Osteoarticular Infections in Infants Under 3 Months of Age |
title_sort |
Osteoarticular Infections in Infants Under 3 Months of Age |
author |
Branco, J |
author_facet |
Branco, J Duarte, M Norte, S Arcangelo, J Alves, P Brito, M Tavares, D Gouveia, C |
author_role |
author |
author2 |
Duarte, M Norte, S Arcangelo, J Alves, P Brito, M Tavares, D Gouveia, C |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE |
dc.contributor.author.fl_str_mv |
Branco, J Duarte, M Norte, S Arcangelo, J Alves, P Brito, M Tavares, D Gouveia, C |
dc.subject.por.fl_str_mv |
Adolescent Anti-Bacterial Agents / therapeutic use Bacteremia* / microbiology Child Cross Infection* / drug therapy Infant Female Male Methicillin-Resistant Staphylococcus aureus* Osteomyelitis* / diagnosis Osteomyelitis* / epidemiology Osteomyelitis* / therapy Retrospective Studies Staphylococcal Infections* / diagnosis Staphylococcal Infections* / drug therapy Staphylococcal Infections* / epidemiology Staphylococcus aureus HDE INF PED HDE ORT PED HDE IMA |
topic |
Adolescent Anti-Bacterial Agents / therapeutic use Bacteremia* / microbiology Child Cross Infection* / drug therapy Infant Female Male Methicillin-Resistant Staphylococcus aureus* Osteomyelitis* / diagnosis Osteomyelitis* / epidemiology Osteomyelitis* / therapy Retrospective Studies Staphylococcal Infections* / diagnosis Staphylococcal Infections* / drug therapy Staphylococcal Infections* / epidemiology Staphylococcus aureus HDE INF PED HDE ORT PED HDE IMA |
description |
Background: Acute osteoarticular infections (OAI) in infants under 3 months of age (≤3M) are rare and remain a diagnostic challenge. Orthopedic complications and functional sequelae have been less well described in this age group. Our aims were to evaluate trends in aetiology, management, and outcomes of OAI ≤ 3M, and to compare these younger children who have OAI with older children. Methods: A longitudinal observational study was conducted of OAI cases admitted to tertiary care pediatric hospital from 2008 to 2018. OAI ≤ 3M was compared with children above 3 months. Clinical, microbiological, imaging, and outcome data were analyzed. Results: We identified 24 (9.1%) of the 263 OAI in children under 3 months. Analyzing OAI ≤ 3M there was a twofold increase since 2014; 54% were males with a median age of 28 days (IQR: 13.5-60.0), 10 (41.7%) were premature and nine (37.5%) had healthcare-associated infections. Microbiological causes were identified in 87.5%, mostly Staphylococcus aureus (57.1%) and Group B Streptococcus (23.8%), and 25% were multidrug-resistant (5 methicillin-resistant S. aureus and 1 Enterobacter cloacae). Bacteremia (100% vs 36.8%, P = 0.037), multidrug resistant bacteria (75% vs 16, P = 0.04), and healthcare-associated infections (100% vs 26.3%, P = 0.014) were associated with sequelae. Comparing OAI ≤ 3M with older children, OAI ≤ 3M were treated with longer antibiotic courses, had more complications and sequelae (17.4% vs 3.2%, P = 0.002). Conclusions: S. aureus is still the most common cause of OAI ≤ 3M, and 25% of causative bacteria were multidrug-resistant bacteria. Complications and sequelae were more frequent in OAI ≤ 3M when compared with older children. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022 2022-01-01T00:00:00Z 2023-05-04T11:56:49Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.17/4508 |
url |
http://hdl.handle.net/10400.17/4508 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Pediatr Int . 2022 Jan;64(1):e15212 10.1111/ped.15212 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Wiley |
publisher.none.fl_str_mv |
Wiley |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799131588589518848 |